Study hints at connection between cocoa and brain blood flow

http://consumer.healthday.com/senior-citizen-information-31/misc-aging-news-10/study-links-hot-cocoa-to-improved-brain-function-in-seniors-679021.html

As different areas of the brain need more energy to complete their tasks, they also need greater blood flow. A new study links drinking cocoa, which is high in antioxidants, to improved scores on a memory test in seniors with low levels of blood flow in their brains. In this small study, brain blood flow improved in the 18 participants whose brain blood flow levels were low. There was no effect among the others who had normal blood flow. The Alzheimer’s Association believes this very preliminary study is not well-designed as a test of an intervention and that no one should start drinking cocoa with the expectation that it will provide cognitive benefits.
Read the article >>

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

http://www.blogtalkradio.com/conversationsincare/2013/08/14/distressed-or-distressingre-framing-behavior-in-alzheimers

I wanted to share with you an episode of Conversations In Care that will be broadcasting Live tomorrow at 1:00pm Central time.
In this episode I will be joined by Eilon Caspi, Ph.D and dementia behavior specialist as we talk about re-framing behavior as a communication tool for the person with Alzheimer’s. We will discuss methods such as Validation Therapy and Need-Driven Dementia Compromised Behavior Model, and how these tools can be used to help prevent agitation and aggression.
Follow the link below to the live show, or if you can not listen in live the same link will take you to the archived show.
http://www.blogtalkradio.com/conversationsincare/2013/08/14/distressed-or-distressingre-framing-behavior-in-alzheimers
I have been honored to have this chosen as a Staff Pick by the Blog Talk Radio Team. I look forward to hearing how you enjoyed the information.
Thank you for joining in the Conversation.
Tami Neumann, CDP
Host of Conversations In Care
tami@conversations-in-care.com

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

http://www.alz.org/join_the_cause_4772.asp?utm_source=DM&utm_medium=email&utm_campaign=email-all

That old vehicle in your garage can now get a second life and make a difference in the fight against Alzheimer’s disease. How? Consider donating your car for the cause!
It’s easy.
We accept cars, trucks, RVs and even boats! We take them whether they are in top shape or just a lump of metal. We’ll even pick up the vehicle from you at your convenience at no cost.
It’s fast.
Once you complete our simple Vehicle Donation Form, a towing service will call you within four business days to schedule a pick-up time.
It’s tax-deductible.
Your car donation is tax-deductible to the full extent of the law.
It feels good!
You don’t have to worry about dealers, ads or calling a tow truck. Your vehicle will help further our mission to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

If you have a vehicle that you are thinking of trading in or selling, consider donating it to the Alzheimer’s Association Donate a Car Program.

When your vehicle is sold, the proceeds will go to the Alzheimer’s Association to help fund research and enhance the lives of all those affected by the disease. You may also be able to deduct the fair market value of your vehicle as a charitable contribution for income tax purposes.

We have partnered with Car Program LLC, which accepts most vehicles, including cars, trucks, trailers, boats and RVs. The donation process is easy by phone.

Donate online:

• Start now with the Vehicle Donation Form. Once your form is processed, a towing service will call you within four business days to schedule an appointment time to pick up your vehicle.
• Get answers to frequently asked questions.
• Ask questions before starting by sending us an email at donateacar@alz.org.

Donate by phone:

• If you have any questions, please call the Donate-A-Car processing center toll-free, seven days a week at 1.800.240.0160.

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

Alzheimer’s disease therapeutics and diagnostics market will reach $8.3 billion in 2017

https://www.asdreports.com/shopexd.asp?id=72558&desc=titlelink&utm_source=ASDReports&utm_medium=email&utm_campaign=ASDR-72558&utm_content=homecare%40optimumseniorcare.com

A new report predicts the world market for Alzheimer’s disease therapeutics and diagnostics will reach $8.3bn in 2017. That revenue forecast and others appear in Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023, published in June 2013.

This report forecasts the Alzheimer’s disease (AD) therapeutics and diagnostics market will achieve strong revenue growth to 2023, especially beyond 2017. By 2017, some clinical trials will have finished and innovative products gained regulatory approval. The scope of the field is widening, with many organisations entering and collaborating.

Rodrigo Gutierrez Gamboa, a pharmaceutical industry analyst, said: “A high unmet need remains for innovative Alzheimer’s therapies that are able to alter the underlying course of this terminal disease. Several of the leading Alzheimer’s drugs have lost market exclusivity in important regions of the market, leaving the market exposed to intensified generic competition. There is also strong market need for diagnostic technologies for the early detection of AD.

“The R&D pipeline for Alzheimer’s therapies and diagnostics remains strong, with promising candidates, despite the series of high-profile failures in the late stages of clinical development. Beyond 2017, the market will be transformed by the introduction of disease-modifying therapies and innovative diagnostic technologies. The potential of new drugs and diagnostics in this market is enormous, given the high prevalence of AD and limited efficacy and utility of therapies and diagnostic tests currently available.”

This new report shows revenue forecasts to 2023 at overall world market, submarket, product and national level. Research, data and analyses cover activities of Pfizer, Eisai, Forest Laboratories, Lundbeck, Novartis and other pharmaceutical, biotechnology and diagnostics companies.

That study discusses R&D and predicts revenues to 2023 in leading national markets. The work analyses the US, Japan, Germany, France, the UK, Spain, Italy, India and China.

Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 therefore adds to our range of analytical reports on industries and markets in healthcare.

Report Details
Alzheimer’s medicine – your guide to technologies, trends and revenues
Where’s treatment of Alzheimer’s disease heading? This new report gives you revenue predictions for those drugs and diagnostic tests from 2013, helping you stay ahead.
There you find financial data, R&D trends, opportunities, and prospects. In particular, you see forecasted sales to 2023 at overall world market, submarket, product, and national level.
Read on, then, to explore that industry and see what its future market could be worth.
Forecasts to 2023 and other analyses to help you stay ahead
Besides revenue forecasting to 2023, you find historical data, growth rates, and market shares. You assess quantitative and qualitative analysis, business news, outlooks, and developments (R&D). You also gain 40 tables, 63 charts, and an interview.
Many opportunities exist for diagnosis and treatment of Alzheimer’s. Our study shows you the most promising and lucrative parts of that CNS market, helping you stay ahead. Now see how you can benefit your research, analyses and decisions, also saving time.
Finding data you need on that neurodegenerative disorder has just got easier. The following sections show how you benefit from our new analysis.
Discover outlooks for the world market and submarkets
Along with prediction of overall world market value to 2023, our report shows you revenue forecasting for main submarkets at world level:

• Medicines for Alzheimer’s disease
• Diagnostics for Alzheimer’s (including biomarkers).

Also our study discusses what stimulates and restrains that market. That analysis helps you identify potential and find ways for your business to develop. Assess brands too.
See forecasts for Alzheimer’s drugs
How will drugs perform to 2023 at world level? Our study predicts individual revenues of three products:

• Namenda
• Aricept
• Exelon.

There you discover how high sales can go, to 2023. You see what’s happening, then, understanding trends, competition, challenges, and opportunities.
You find geographical revenue predictions too.
Discover prospects of national markets for those anti-dementia products
Developments worldwide expand the market for diagnosing, treating and monitoring neurodegenerative disorders. Developed and developing national markets hold high potential from 2013.
Our analyses show you individual revenue forecasts to 2023 for nine national markets and a regional block:

• US
• Japan
• Germany, France, UK, Italy, and Spain (EU5)
• Europe (grouped forecast)
• India and China.

There you find potential. Large companies and specialty biopharma and diagnostics firms face many opportunities. Our study explains, assessing developments to help your work.
What affects producers of those diagnostic tests and medicines?
Our report discusses issues and events affecting that industry and market from 2013, including these:

• Research and development (R&D) – drugs, diagnostic tests, and related technologies
• Disease prevalence – expanding patient populations
• Disease-modifying drugs and obstacles to cures
• Regulatory guidelines – changes and opportunities.

The study also discusses other aspects of diagnosing and treating Alzheimer’s:

• Needs for Alzheimer’s treatments
• Drugs and related technologies to transform the market
• Biomarkers and diagnostic imaging technologies, including structural, functional, and molecular imaging
• Deep brain stimulation (functional neuromodulation)
• Intellectual property (IP), licensing agreements and partnerships.

That way, you explore the industry’s strengths, weaknesses, opportunities, and threats. You also analyse it through Porter’s five forces.
See, then, what the future holds.
Prominent companies in that biomedical field and 2017 market value
Our new study predicts the world market for Alzheimer’s products will reach $8.3bn in 2017, and expand fast – especially from 2018.
Disease-modifying therapies will transform that market. New drugs hold great potential from 2018 to 2023, given the prevalence of Alzheimer’s and needs for more-effective treatments.
Our work thus shows you what technologies, products, and organisations hold greatest potential. In particular, the analysis investigates these companies:

• Pfizer
• Eisai
• Forest Laboratories
• Lundbeck
• Novartis
• TauRx Therapeutics
• AC Immune.

There you assess results, product ranges, R&D pipelines, and outlooks.
Prospects for Alzheimer’s products and R&D are strong, and from 2013 there will arise many opportunities. Our work shows you the possibilities there, helping you stay ahead.
Eight ways Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 helps you
In particular, then, our investigation gives you the following knowledge:

• Revenue to 2023 for the world market – discover that industry’s overall sales potential
• Revenues to 2023 for world-level submarkets – investigate the potential of its components, finding the most promising places for investments and revenues
• Revenues to 2023 for top products – find sales outlooks for top brands, seeing how they can compete and succeed
• Forecasts to 2023 for national markets in North America, Europe, and Asia – discover the best countries for revenues and potential growth
• Assessments of prominent companies – hear about developers and manufacturers’ activities, results, and outlooks
• Review of R&D – explore progress in research and development, finding technological and medical possibilities for that neurological disorder
• Competition and opportunities – investigate what shapes that market’s future, including ways to develop business
• Analysis of what stimulates and restrains that industry and market – assess challenges and strengths, helping you compete and get advantages.

You gain information found nowhere else
That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.
With our study you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.
Assess progress and potential now, seeing what you can gain.
Discover predictions for Alzheimer’s-related products by ordering now
Our study lets you find data, trends, opportunities, and sales predictions for Alzheimer’s medicine. Avoid missing out – please order our new report now.

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

Man takes long walk to Atlanta to raise money to fight Alzheimer’s

http://www.dailyherald.com/article/20130802/news/708029934/

William Glass of Lombard, Ill., has set off on a 750-mile trek to Atlanta — on foot — to help fight Alzheimer’s disease. He hopes to raise $10,000 for the Alzheimer’s Association in part to honor his mother, Eileen, who was diagnosed with Alzheimer’s in 2010: “I just want to get out the awareness of how many more people have this disease and how much more funding we need.”
Read the article >>
You can Walk to End Alzheimer’s® >>

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/